Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an enveloped, positive sense, single stranded RNA (+ssRNA) virus, belonging to the genus Betacoronavirus and family Coronaviridae. It is primarily transmitted from infected persons to healthy ones through inhalation of virus-laden respiratory droplets. After an average incubation period of 2-14 days, the majority of infected individuals remain asymptomatic and/or mildly symptomatic, whereas the remaining individuals manifest a myriad of clinical symptoms, including fever, sore throat, dry cough, fatigue, chest pain, and breathlessness. SARS-CoV-2 exploits the angiotensin converting enzyme 2 (ACE-2) receptor for cellular invasion, and lungs are amongst the most adversely affected organs in the body. Thereupon, immune responses are elicited, which may devolve into a cytokine storm characterized by enhanced secretion of multitude of inflammatory cytokines/chemokines and growth factors, such as interleukin (IL)-2, IL-6, IL-7, IL-8, IL-9, tumor necrosis factor alpha (TNF-α), granulocyte colony-stimulating factor (GCSF), basic fibroblast growth factor 2 (bFGF2), monocyte chemotactic protein-1 (MCP1), interferon-inducible protein 10 (IP10), macrophage inflammatory protein 1A (MIP1A), platelet-derived growth factor subunit B (PDGFB), and vascular endothelial factor (VEGF)-A. The systemic persistence of inflammatory molecules causes widespread histological injury, leading to functional deterioration of the infected organ(s). Although multiple treatment modalities with varying effectiveness are being employed, nevertheless, there is no curative COVID-19 therapy available to date. In this regard, one plausible supportive therapeutic modality may involve administration of mesenchymal stem cells (MSCs) and/or MSC-derived bioactive factors-based secretome to critically ill COVID-19 patients with the intention of accomplishing better clinical outcome owing to their empirically established beneficial effects. MSCs are well established adult stem cells (ASCs) with respect to their immunomodulatory, anti-inflammatory, anti-oxidative, anti-apoptotic, pro-angiogenic, and pro-regenerative properties. The immunomodulatory capabilities of MSCs are not constitutive but rather are highly dependent on a holistic niche. Following intravenous infusion, MSCs are known to undergo considerable histological trapping in the lungs and, therefore, become well positioned to directly engage with lung infiltrating immune cells, and thereby mitigate excessive inflammation and reverse/regenerate damaged alveolar epithelial cells and associated tissue post SARS-CoV-2 infection. Considering the myriad of abovementioned biologically beneficial properties and emerging translational insights, MSCs may be used as potential supportive therapy to counteract cytokine storms and reduce disease severity, thereby facilitating speedy recovery and health restoration.
Keywords: Severe Acute Respiratory Syndrome Coronavirus-2; angiotensin converting enzyme 2; cytokine storm; immunomodulation; mesenchymal stem cells.
【저자키워드】 Cytokine storm, angiotensin converting enzyme 2, immunomodulation, severe acute respiratory syndrome coronavirus-2, mesenchymal stem cells., 【초록키워드】 COVID-19, Treatment, stem cells, SARS-CoV-2, Necrosis, Macrophage, Tumor, Cytokine storm, immune response, therapy, Clinical symptoms, Anti-inflammatory, fatigue, IL-6, SARS-COV-2 infection, disease severity, angiotensin converting enzyme 2, immunomodulation, interferon, lung, Mesenchymal stem cells, MSCs, cytokine, severe acute respiratory syndrome coronavirus-2, chemokines, severe acute respiratory syndrome Coronavirus, virus, angiotensin converting enzyme, coronavirus 2, Betacoronavirus, monocyte, RNA, Clinical outcome, Growth factors, ACE-2, Severe acute respiratory syndrome, Protein, Deterioration, Health, interleukin, tumor necrosis factor, Critically ill, Asymptomatic, persistence, symptomatic, immune responses, Lungs, Fever, immunomodulatory, therapeutic, inhalation, Incubation period, Effectiveness, IL-8, Platelet, Alpha, immune cells, epithelial cells, Intention, Inflammatory cytokines, receptor, respiratory, TNF-α, IL-7, alveolar epithelial cells, IP10, cellular, administration, angiotensin, Inflammatory, Injury, MSC, COVID-19 patient, Invasion, chest pain, critically ill COVID-19 patients, Cytokine storms, intravenous, stem cell, granulocyte, tumor necrosis, intravenous infusion, supportive therapy, Secretome, sore throat, breathlessness, fibroblast growth factor, platelet-derived growth factor, Respiratory droplets, tumor necrosis factor alpha, endothelial, granulocyte colony-stimulating factor, Vascular, colony-stimulating factor, subunit, acute respiratory syndrome coronavirus, tissue, acute respiratory syndrome coronavirus 2, enzyme, infected individual, infected individuals, individual, dry cough, secretion, average, acute respiratory syndrome coronavirus-2, infiltrating immune cells, excessive inflammation, family Coronaviridae, genus, myriad, growth factor, multitude, positive, organ, monocyte chemotactic protein-1, MCP1, fibroblast, widespread, mitigate, Effects, genus Betacoronavirus, IL-9, GCSF, immunomodulatory capabilities, MIP1A, PDGFB, affected, healthy, transmitted, characterized, functional, undergo, majority, dependent on, cause, reduce, elicited, anti-apoptotic, translational, damaged, engage, alveolar epithelial cell, histological, anti-oxidative, curative, immunomodulatory capability, inflammatory protein, positioned, 【제목키워드】 aspect, STEM,